Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. - Wikidata - wikimedia - TriplyDB

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.

http://www.wikidata.org/entity/Q55042194

about

The detection, treatment, and biology of epithelial ovarian cancer Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease Prevention A Comparative Analysis of Genetic and Epigenetic Events of Breast and Ovarian Cancer Related to Tumorigenesis Emotional and sexual concerns in women undergoing pelvic surgery and associated treatment for gynecologic cancer The Consequences of a BRCA Mutation in Women Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers The molecular fingerprint of high grade serous ovarian cancer reflects its fallopian tube origin Challenging and complex decisions in the management of the BRCA mutation carrier The lack of clinical value of peritoneal washing cytology in high risk patients undergoing risk-reducing salpingo-oophorectomy: a retrospective study and review The cell of origin of ovarian epithelial tumours Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.Twenty questions in genetic medicine--an assessment of World Wide Web databases for genetics information at the point of care.Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come?Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine Data generation for the Cox proportional hazards model with time-dependent covariates: a method for medical researchers.Do breast cancer survivors benefit from prophylactic removal of uterus and ovaries? A population-based data linkage replication study.Incorporating medical interventions into carrier probability estimation for genetic counseling.The preclinical natural history of serous ovarian cancer: defining the target for early detection Major clinical research advances in gynecologic cancer in 2016: 10-year special edition.Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers.Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery.Precursor lesions of high-grade serous ovarian carcinoma: morphological and molecular characteristics.Two decades after BRCA: setting paradigms in personalized cancer care and prevention BRCA-associated ovarian cancer: from molecular genetics to risk management A simulation model to predict the impact of prophylactic surgery and screening on the life expectancy of BRCA1 and BRCA2 mutation carriers.International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy.Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.Clinical management of hereditary breast cancer syndromes.Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers.10 rare tumors that warrant a genetics referral.Coming into focus: the nonovarian origins of ovarian cancer.Single-incision bilateral laparoscopic oophorectomy.New views on the pathogenesis of high-grade pelvic serous carcinoma with suggestions for advancing future research Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis.

P2860

Q21198791-4E890661-91C4-43E1-A575-D9AD935FC06B Q24654487-432470E5-EBC1-4EA7-A2E0-173C78D673AA Q26744525-5A62C8D4-97E1-4149-BA3D-42A423683E47 Q26746952-076C3901-D87C-4892-AC51-74D27357C8BD Q26773707-4969D5F9-EE48-46A4-91A7-D850372B51E3 Q26777891-39273724-6232-491D-97DF-D7DBAC478317 Q26822545-247AC42B-7FFB-4FF6-AD68-AE0850B9BD62 Q27003935-7C7B3F62-06E8-4DA1-9388-5BE7941BDB10 Q27008375-B307A536-5795-4275-803E-C8B22A5D3910 Q27026559-4AD046F2-C5CE-4619-A914-80CF41972C16 Q28077192-D26CF753-9447-4A9E-9ADC-3AF84F02ADB5 Q28302089-55FA362D-C9B7-4C30-8C82-0F289437D766 Q30370475-451559A6-52C6-4439-95A4-D3AFB788079C Q30483973-0FC85067-0B8D-460E-938B-03A09A4A2FD9 Q30487580-E532805B-04E6-4B32-83A8-A9716E944D0E Q30513982-3C93D647-E13F-43C0-841F-C2DBF826D531 Q30665555-7AA25FBB-37FC-4A17-AB65-0ED341BCA01D Q31102791-31B2BEBF-9FC7-470E-8903-C706F42D7CFD Q33279688-31D663B6-9697-4204-814B-9132BA4BB894 Q33487678-12A0ACE7-9FAE-447D-ACAF-C0545580BDB0 Q33563963-85FEF67A-7920-479C-92EF-81AD9B54BDC5 Q33564013-82D037F3-9EBF-4331-A87D-8BAFE73C8A74 Q33606561-B41CA5CF-A41A-4370-9F7A-75D2F9775B77 Q33633402-C32B5F55-71DB-42A5-92DB-C3B55910A8D3 Q33668934-4D501887-3BA9-4AD3-B2D3-D717AC3E1341 Q33723561-E729214B-A4BD-4248-8B6F-ADB4B8DDE740 Q33815261-D81B8392-D7A6-451A-8D30-2D1808A680A6 Q33820594-27256B4E-C42B-4756-82B0-623C759F9EBC Q34032766-AEF86388-7796-439D-9B83-A4D02345470F Q34097351-E0EC5E8E-0432-4B96-8A9E-3E0F1A4E5958 Q34116505-A53B91BE-F7F9-48FF-BC70-705A2B011688 Q34126089-E984B9F4-4820-45C0-8BA4-378B76DB35E7 Q34135443-87D517DA-8101-4351-B048-FE7F460A9411 Q34167563-FE872BE6-1452-4E5B-AB4F-4E6E44EA9E11 Q34172655-F872A3F7-E660-4A18-BA57-C5897C74A968 Q34325954-00476D8D-C27A-4CC6-A91F-99EA4AC05EF7 Q34378112-2C83D8FD-EE24-4D6D-84AF-6318DCE47B7D Q34406653-10EFFE69-02B0-44A7-A3D7-659BF4074A09 Q34543315-E9D96431-2426-4561-AB2A-7A3E40B7DA60 Q34625221-BD1569FC-06D5-4AB4-9693-6F87E7C2EFBB

P2860

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.

http://www.wikidata.org/entity/Q55042194

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Salpingo-oophorectomy and the ...... ith a BRCA1 or BRCA2 Mutation.

@en

Salpingo-oophorectomy and the ...... ith a BRCA1 or BRCA2 Mutation.

@nl

type

label

Salpingo-oophorectomy and the ...... ith a BRCA1 or BRCA2 Mutation.

@en

Salpingo-oophorectomy and the ...... ith a BRCA1 or BRCA2 Mutation.

@nl

prefLabel

Salpingo-oophorectomy and the ...... ith a BRCA1 or BRCA2 Mutation.

@en

Salpingo-oophorectomy and the ...... ith a BRCA1 or BRCA2 Mutation.

@nl

P1433

Q55042194-6C2F62BD-9815-4A3A-B4B2-6F9B62C762BD

P1476

Q55042194-56C853A8-1267-4D4C-AE65-4124F5D90530

P2093

Q55042194-3892E5FA-D284-4BBD-8A2D-19635771F099

Q55042194-3D89C4A1-C8F6-47C2-B935-3E2E6F98BDE4

Q55042194-404E2503-AF1A-402A-9DFD-6F7373A9F764

Q55042194-44F25FF3-1C63-451E-8D05-B2003CA5E400

Q55042194-59A6B75A-FA0F-4C43-A6A3-3BC39CFFEFDD

Q55042194-6E6BFAD4-B0AF-417C-AD2F-FBC97FA70BD6

Q55042194-78346D5B-A6E9-41FD-A2B6-655BF4ABFD89

Q55042194-78B9998A-E84B-46D4-8EB9-A2A0F984E515

Q55042194-7B740FA3-8E0F-4F54-8F58-6D5E1A7D7EAE

Q55042194-888E7ABE-9F15-4A31-A15D-0C2B732A2A4F

P304

Q55042194-70012927-18D8-4BEB-9AF9-CEB185BADC51

P31

Q55042194-65B90F97-D7C5-466A-A4DA-A840B00DD482

P356

Q55042194-365AA1F4-8BA6-40B7-81A2-9EE8C00465D6

P407

Q55042194-09FB6527-C6DF-4678-A28A-47A14FDC49B6

P433

Q55042194-32E94FA7-102D-4D98-8D75-1D0FD9754444

P478

Q55042194-4FC6148F-FACE-4C07-9682-FD734DFAACDF

P50

Q55042194-0618C9EB-95C8-4921-985E-CFE81C24127D

Q55042194-34C586AE-EAAE-4415-83E6-AF412126C4DB

Q55042194-45654680-1D77-4EA9-9B85-AD10CE30F32D

Q55042194-5FD78DD5-E8F1-4FBC-9218-79912F219ABD

Q55042194-CFC1EC7C-737E-480D-AE29-D9C4863997BB

Q55042194-E58EDDC2-30D5-4A13-99B8-2B7B174C4709

Q55042194-FF9BBD4F-F005-4FD2-A9D7-472768445625

P577

Q55042194-0397CA38-D9F7-44B8-915F-CFE57C395C90

P5875

Q55042194-1964AD08-DEFC-4F53-ACC0-E4CF88C26BB2

P698

Q55042194-C68FFB8B-673A-481B-B1D3-964854F43A33

P921

Q55042194-325524C4-191A-4EA9-AE79-9D93166043C5

Q55042194-6399A183-4003-4644-8726-760BAC671FA4

P356

P1433

Journal of the American Medical Association

P1476

Salpingo-oophorectomy and the ...... ith a BRCA1 or BRCA2 Mutation.

@en

P2093

Amy Finch

http://www.w3.org/2001/XMLSchema#string

Babara Pasini

http://www.w3.org/2001/XMLSchema#string

Barry Rosen

http://www.w3.org/2001/XMLSchema#string

Beth Karlan

http://www.w3.org/2001/XMLSchema#string

Charis Eng

http://www.w3.org/2001/XMLSchema#string

Charmaine Kim-Sing

http://www.w3.org/2001/XMLSchema#string

Eitan Friedman

http://www.w3.org/2001/XMLSchema#string

Henry T Lynch

http://www.w3.org/2001/XMLSchema#string

Hereditary Ovarian Cancer Clinical Study Group

http://www.w3.org/2001/XMLSchema#string

Jane McLennan

http://www.w3.org/2001/XMLSchema#string

P304

185-192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.296.2.185

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

296

http://www.w3.org/2001/XMLSchema#string

P50

Dominique Stoppa-Lyonnet

William D Foulkes

Steven A. Narod

Fergus J. Couch

Jeffrey N Weitzel

Olufunmilayo Olopade

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6951056

http://www.w3.org/2001/XMLSchema#string

P698

16835424

http://www.w3.org/2001/XMLSchema#string

P921